1-7 of 7
cost effectiveness
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cost-effectiveness of magnetic resonance imaging for diagnosing recurrent ipsilateral deep vein thrombosis

Clinical Trials & Observations
Lisette F. van Dam, Wilbert B. van den Hout, Gargi Gautam, Charlotte E. A. Dronkers, Waleed Ghanima, Jostein Gleditsch, Anders von Heijne, Herman M. A. Hofstee, Marcel M. C. Hovens, Menno V. Huisman, Stan Kolman, Albert T. A. Mairuhu, Mathilde Nijkeuter, Marcel A. van de Ree, Cornelis J. van Rooden, Robin E. Westerbeek, Jan Westerink, Eli Westerlund, Lucia J. M. Kroft, Frederikus A. Klok
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1369–1378.
https://doi.org/10.1182/bloodadvances.2020003849
Published: 2021
Includes: Supplemental data
Journal Articles

Cost-effectiveness of azacitidine and venetoclax in unfit patients with previously untreated acute myeloid leukemia

Kishan K. Patel, Amer M. Zeidan, Rory M. Shallis, Thomas Prebet, Nikolai Podoltsev, Scott F. Huntington
Journal: Blood Advances
Blood Adv (2021) 5 (4): 994–1002.
https://doi.org/10.1182/bloodadvances.2020003902
Published: 2021
Includes: Supplemental data
Journal Articles

Systems-based hematology: highlighting successes and next steps

Jori E. May, Patrick C. Irelan, Kailee Boedeker, Emily Cahill, Steven Fein, David A. Garcia, Lisa K. Hicks, Janice Lawson, Ming Y. Lim, Colleen T. Morton, Anita Rajasekhar, Satish Shanbhag, Marc S. Zumberg, Robert M. Plovnick, Nathan T. Connell
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4574–4583.
https://doi.org/10.1182/bloodadvances.2020002947
Published: 2020
Journal Articles

Development of a clinical hematology and stem cell transplantation program to provide state-of-the-art and cost-effective treatment to patients: a successful collaboration between a medical college in India and a leading medical university in the United States

Rasmi Palassery, Santhosh Devadas, Sumati Hiregouder, Vinayak Maka, Kalpana Kumari, Nalini Kilara, Damiano Rondelli
Journal: Blood Advances
Blood Adv (2019) 3 (Supplement 1): 23–26.
https://doi.org/10.1182/bloodadvances.2019GS121428
Published: 2019
Journal Articles

Analysis of the cost-effectiveness of treatment strategies for CML with incorporation of treatment discontinuation

Clinical Trials & Observations
Chihiro Yamamoto, Hirotomo Nakashima, Takashi Ikeda, Shin-ichiro Kawaguchi, Yumiko Toda, Shoko Ito, Kiyomi Mashima, Takashi Nagayama, Kento Umino, Daisuke Minakata, Hirofumi Nakano, Kaoru Morita, Ryoko Yamasaki, Miyuki Sugimoto, Yuko Ishihara, Masahiro Ashizawa, Kaoru Hatano, Kazuya Sato, Iekuni Oh, Shin-ichiro Fujiwara, Masuzu Ueda, Ken Ohmine, Kazuo Muroi, Yoshinobu Kanda
Journal: Blood Advances
Blood Adv (2019) 3 (21): 3266–3277.
https://doi.org/10.1182/bloodadvances.2019000745
Published: 2019
Includes: Supplemental data
Journal Articles

Cost-effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia in older adults without deletion 17p

James I. Barnes, Vasu Divi, Adrian Begaye, Russell Wong, Steven Coutre, Douglas K. Owens, Jeremy D. Goldhaber-Fiebert
Journal: Blood Advances
Blood Adv (2018) 2 (15): 1946–1956.
https://doi.org/10.1182/bloodadvances.2017015461
Published: 2018
Includes: Supplemental data
Journal Articles

Gene therapy in hemophilia A: a cost-effectiveness analysis

Nicoletta Machin, Margaret V. Ragni, Kenneth J. Smith
Journal: Blood Advances
Blood Adv (2018) 2 (14): 1792–1798.
https://doi.org/10.1182/bloodadvances.2018021345
Published: 2018